Literature DB >> 16106430

Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia.

Sue C Kaste1, Shesh N Rai, Katherine Fleming, Elizabeth A McCammon, Frances A Tylavsky, Robert K Danish, Susan R Rose, Cheri D Sitter, Ching-Hon Pui, Melissa M Hudson.   

Abstract

BACKGROUND: There is little information about factors modulating bone mineral density (BMD) in survivors of childhood acute lymphoblastic leukemia (ALL). PROCEDURE: We analyzed data from 57 survivors (26 male, 52 Caucasian) who underwent two serial quantitative computed tomography (QCT) studies of BMD. Using multiple linear regression, we evaluated the association of BMD change with demographic variables, treatment history, hormone therapy, exercise, and tobacco and alcohol use.
RESULTS: The median age was 3.4 years (range, 0.9-17.4 years) at diagnosis of ALL; the median age at the first QCT (Study I) was 15.0 years (range, 10.6-31.0 years) and at the second QCT (Study II) was 18.2 years (range, 14.2-35.3 years). Mean height increased 4.7 cm and mean weight increased 8.8 kg between Studies I and II. While the mean BMD increased 9.33 mg/cc (P = 0.003), the BMD Z-score increased only slightly (0.21 SD, P = 0.035). Cortical bone density increased significantly (approximately 25.3 mg/cc; P = 0.001), but the ratio of trabecular to cortical BMD decreased significantly (P = 0.045). Factors independently associated with unfavorable BMD changes included older age at diagnosis (P = 0.001), female sex (P = 0.018), and nutritional supplementation (0.032). Alcohol (P = 0.009) was an unfavorable factor in a univariable analysis.
CONCLUSIONS: Bone mineral accretion during adolescence is attenuated in childhood ALL survivors by a comparative deficit in trabecular versus cortical bone deposition. BMD is influenced favorably by exercise in early adolescence and unfavorably by the use of nutritional supplements and alcohol. These results provide new information about behavioral factors that affect bone accrual in survivors of childhood ALL and warrant definitive evaluation in a larger cohort.

Entities:  

Mesh:

Year:  2006        PMID: 16106430     DOI: 10.1002/pbc.20553

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  33 in total

1.  Physical therapy and chiropractic use among childhood cancer survivors with chronic disease: impact on health-related quality of life.

Authors:  Michele Montgomery; Sujuan Huang; Cheryl L Cox; Wendy M Leisenring; Kevin C Oeffinger; Melissa M Hudson; Jill Ginsberg; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2010-10-05       Impact factor: 4.442

2.  Differential diagnosis and work-up of elevations of alkaline phosphatase following therapy for pediatric cancer.

Authors:  Jessica R Roberson; Sue C Kaste; Victor M Santana; Wayne L Furman
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

3.  A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.

Authors:  Etan Orgel; Nicole M Mueske; Richard Sposto; Vicente Gilsanz; Tishya A L Wren; David R Freyer; Anna M Butturini; Steven D Mittelman
Journal:  Leuk Lymphoma       Date:  2017-02-20

4.  Milestones in the curability of pediatric cancers.

Authors:  Melissa M Hudson; Michael P Link; Joseph V Simone
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

5.  Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant.

Authors:  Jill H Simmons; Eric J Chow; Elizabeth Koehler; Adam Esbenshade; Lesley-Ann Smith; Jean Sanders; Debra Friedman
Journal:  Pediatr Blood Cancer       Date:  2010-12-22       Impact factor: 3.167

6.  Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Carmen L Wilson; Kimberley Dilley; Kirsten K Ness; Wendy L Leisenring; Charles A Sklar; Sue C Kaste; Marilyn Stovall; Daniel M Green; Gregory T Armstrong; Leslie L Robison; Nina S Kadan-Lottick
Journal:  Cancer       Date:  2012-05-17       Impact factor: 6.860

7.  Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.

Authors:  J G Gurney; S C Kaste; W Liu; D K Srivastava; W Chemaitilly; K K Ness; J Q Lanctot; R P Ojha; K A Nottage; C L Wilson; Z Li; L L Robison; M M Hudson
Journal:  Pediatr Blood Cancer       Date:  2014-02-28       Impact factor: 3.167

8.  Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design.

Authors:  Shesh N Rai; Melissa M Hudson; Elizabeth McCammon; Laura Carbone; Francis Tylavsky; Karen Smith; Harriet Surprise; John Shelso; Chin-Hon Pui; Sue Kaste
Journal:  Contemp Clin Trials       Date:  2008-05-18       Impact factor: 2.226

9.  Trial design: The St. Jude Children's Research Hospital Cancer Survivors Tobacco Quit Line study.

Authors:  Taghrid Asfar; Robert C Klesges; Stacy D Sanford; Deborah Sherrill-Mittleman; Leslie L Robison; Melissa M Hudson; Grant Somes; James M Boyett; Harry Lando
Journal:  Contemp Clin Trials       Date:  2009-09-18       Impact factor: 2.226

10.  Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits.

Authors:  Sue C Kaste; Monika L Metzger; Anum Minhas; Zang Xiong; Shesh N Rai; Kirsten K Ness; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.